aceutical, biotechnology, medical device, product, service, biopharmaceutical and translational entities, as well as government agencies. We are the largest and leading provider of real estate to the broad and diverse life science industry with an asset base, as of December 31, 2008, of approximately 12.6 million rentable square feet consisting of 159 properties approximating 11.7 million rentable square feet (including spaces undergoing active redevelopment) and properties undergoing ground-up development approximating 875,000 rentable square feet.
The common stock will be issued pursuant to an effective registration statement on Form S-3 that was previously filed with the Securities and Exchange Commission. This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the Company's common stock, nor shall there be any sale of the common stock in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
Copies of the prospectus supplement relating to this offering, when available, may be obtained by contacting: Merrill Lynch & Co., 250 Vesey Street, New York, New York 10080, or by calling 212-449-1000; Citi, Prospectus Department, Brooklyn Army Terminal, 140 58th Street, 8th Floor, Brooklyn, New York 11220 or by calling 1-800-831-9146; or J.P. Morgan Securities Inc., National Statement Processing, Prospectus Library, 4 Chase Metrotech Center, CS Level, Brooklyn, New York 11245, or by calling 718-242-8002.
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding the Company's offering of common stock (including an over-allotment option), its intended us
Page: 1 2 3 Related biology technology :1
|SOURCE Alexandria Real Estate Equities, Inc.|
Copyright©2009 PR Newswire.
All rights reserved
. Alexandria Real Estate Equities, Inc. Reports Third Quarter 2007 Results2
. Alexandria Real Estate Equities, Inc. Features Green Buildings and Sustainable Operations Initiatives and Tour at 2008 BIO3
. Coherent Announces Restatement Related to Stock-Based Compensation4
. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement5
. Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 20066
. Unigene Restates Policy on Analyst Reports7
. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate8
. Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates9
. Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate10
. Norton & Associates Inc. Adds $3bnUSD Commercial Real Estate Investment P & L Management Holding Group; US Property Portfolio Inc.11
. BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors